Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 26;10(5):e0076322.
doi: 10.1128/spectrum.00763-22. Epub 2022 Aug 25.

Comparison of Different Label-Free Raman Spectroscopy Approaches for the Discrimination of Clinical MRSA and MSSA Isolates

Affiliations

Comparison of Different Label-Free Raman Spectroscopy Approaches for the Discrimination of Clinical MRSA and MSSA Isolates

Aikaterini Pistiki et al. Microbiol Spectr. .

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is classified as one of the priority pathogens that threaten human health. Resistance detection with conventional microbiological methods takes several days, forcing physicians to administer empirical antimicrobial treatment that is not always appropriate. A need exists for a rapid, accurate, and cost-effective method that allows targeted antimicrobial therapy in limited time. In this pilot study, we investigate the efficacy of three different label-free Raman spectroscopic approaches to differentiate methicillin-resistant and -susceptible clinical isolates of S. aureus (MSSA). Single-cell analysis using 532 nm excitation was shown to be the most suitable approach since it captures information on the overall biochemical composition of the bacteria, predicting 87.5% of the strains correctly. UV resonance Raman microspectroscopy provided a balanced accuracy of 62.5% and was not sensitive enough in discriminating MRSA from MSSA. Excitation of 785 nm directly on the petri dish provided a balanced accuracy of 87.5%. However, the difference between the strains was derived from the dominant staphyloxanthin bands in the MRSA, a cell component not associated with the presence of methicillin resistance. This is the first step toward the development of label-free Raman spectroscopy for the discrimination of MRSA and MSSA using single-cell analysis with 532 nm excitation. IMPORTANCE Label-free Raman spectra capture the high chemical complexity of bacterial cells. Many different Raman approaches have been developed using different excitation wavelength and cell analysis methods. This study highlights the major importance of selecting the most suitable Raman approach, capable of providing spectral features that can be associated with the cell mechanism under investigation. It is shown that the approach of choice for differentiating MRSA from MSSA should be single-cell analysis with 532 nm excitation since it captures the difference in the overall biochemical composition. These results should be taken into consideration in future studies aiming for the development of label-free Raman spectroscopy as a clinical analytical tool for antimicrobial resistance determination.

Keywords: 532-nm single-cell analysis; 785 nm fiber probe; MRSA; Raman microscopy; Raman spectroscopy; UV resonance Raman spectroscopy; single-cell analysis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

FIG 1
FIG 1
Mean Raman spectrum (A) and difference spectrum (B) of MRSA and MSSA strains by using 785 nm excitation on bacterial colonies directly on the petri dish. arb. u, arbitrary units. Spectra are shifted vertically for clarity.
FIG 2
FIG 2
Mean Raman spectrum (A) and difference spectrum (B) of MRSA and MSSA strains by using UVRR. arb. u, arbitrary units. Spectra are shifted vertically for clarity.
FIG 3
FIG 3
Mean Raman spectrum (A) and difference spectrum (B) of MRSA and MSSA strains by using single-cell analysis with 532 nm excitation. arb. u, arbitrary units. Spectra are shifted vertically for clarity.

Similar articles

Cited by

References

    1. Hay SI, Rao PC, Dolecek C, Day NPJ, Stergachis A, Lopez AD, Murray CJL. 2018. Measuring and mapping the global burden of antimicrobial resistance. BMC Med 16:78. doi:10.1186/s12916-018-1073-z. - DOI - PMC - PubMed
    1. van Belkum A, Melles DC, Nouwen J, van Leeuwen WB, van Wamel W, Vos MC, Wertheim HF, Verbrugh HA. 2009. Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus. Infect Genet Evol 9:32–47. doi:10.1016/j.meegid.2008.09.012. - DOI - PubMed
    1. Hassoun A, Linden PK, Friedman B. 2017. Incidence, prevalence, and management of MRSA bacteremia across patient populations—a review of recent developments in MRSA management and treatment. Crit Care 21:211. doi:10.1186/s13054-017-1801-3. - DOI - PMC - PubMed
    1. Stein C, Tittelbach J, Monecke S, Weis S, Makarewicz O, Ehricht R, Pletz M. 2018. Rethinking the molecular diagnostics for methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 39:495–496. doi:10.1017/ice.2018.17. - DOI - PubMed
    1. Kourtis AP, Hatfield K, Baggs J, Mu Y, See I, Epson E, Nadle J, Kainer MA, Dumyati G, Petit S, Ray SM, Ham D, Capers C, Ewing H, Coffin N, McDonald LC, Jernigan J, Cardo D, Emerging Infections Program MRSA author group . 2019. Vital signs: epidemiology and recent trends in methicillin-resistant and in methicillin-susceptible Staphylococcus aureus bloodstream infections-United States. MMWR Morb Mortal Wkly Rep 68:214–219. doi:10.15585/mmwr.mm6809e1. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances